The DOI matches its OpenAlex record; 15 of the 15 references it cites were found in a registry or an index.
The vitamin D hormone and its nuclear receptor: molecular actions and disease states
Open accessAbstract
Vitamin D plays a major role in bone mineral homeostasis by promoting the transport of calcium and phosphate to ensure that the blood levels of these ions are sufficient for the normal mineralization of type I collagen matrix in the skeleton. In contrast to classic vitamin D-deficiency rickets, a number of vitamin D-resistant rachitic syndromes are caused by acquired and hereditary defects in the metabolic activation of the vitamin to its hormonal form, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), or in the subsequent functions of the hormone in target cells. The actions of 1,25(OH)2D3 are mediated by the nuclear vitamin D receptor (VDR), a phosphoprotein which binds the hormone with-high affinity and regulates the expression of genes via zinc finger-mediated DNA binding and protein-protein interactions. In hereditary hypocalcemic vitamin D-resistant rickets (HVDRR), natural mutations in human VDR that confer patients with tissue insensitivity to 1,25(OH)2D3 are particularly instructive in revealing VDR structure function relationships. These mutations fall into three categories: (i) DNA binding/nuclear localization, (ii) hormone binding and (iii) heterodimerization with retinoid X receptors (RXRs). That all three classes of VDR mutations generate the HVDRR phenotype is consistent with a basic model of the active receptor as a DNA-bound, 1,25(OH)2D3-liganded heterodimer of VDR and RXR. Vitamin D responsive elements (VDREs) consisting of direct hexanucleotide repeats with a spacer of three nucleotides have been identified in the promoter regions of positively controlled genes expressed in bone, such as osteocalcin, osteopontin, beta 3-integrin and vitamin D 24-OHase. The 1,25(OH)2D3 ligand promotes VDR-RXR heterodimerization and specific, high affinity VDRE binding, whereas the ligand for RXR, 9-cis retinoic acid (9-cis RA), is capable of suppressing 1,25(OH)2D3-stimulated transcription by diverting RXR to form homodimers. However, initial 1,25(OH)2D3 liganding of a VDR monomer renders it competent not only to recruit RXR into a heterodimer but also to conformationally silence the ability of its RXR partner to bind 9-cis RA and dissociate the heterodimer. Additional probing of protein-protein interactions has revealed that VDR also binds to basal transcription factor IIB (TFIIB) and, in the presence of 1,25(OH)2D3, an RXR-VDR-TFIIB ternary complex can be created in solution. Moreover, for transcriptional activation by 1,25(OH)2D3, both VDR and RXR require an intact short amphipathic alpha-helix, known as AF-2, positioned at their extreme C-termini. Because the AF-2 domains participate neither in VDR-RXR heterodimerization nor in TFIIB association, it is hypothesized that they contact, in a ligand-dependent fashion, transcriptional coactivators such as those of the steroid receptor coactivator family, constituting yet a third protein-protein interaction for VDR. Therefore, in VDR-mediated transcriptional activation, 1,25(OH)2D3 binding to VDR alters the conformation of the ligand binding domain such that it: (i) engages in strong heterodimerization with RXR to facilitate VDRE binding, (ii) influences the RXR ligand binding domain such that it is resistant to the binding of 9-cis RA but active in recruiting coactivator to its AF-2 and (iii) presents the AF-2 region in VDR for coactivator association. The above events, including bridging by coactivators to the TATA binding protein and associated factors, may position VDR such that it is able to attract TFIIB and the balance of the RNA polymerase II transcription machinery, culminating in repeated transcriptional initiation of VDRE-containing, vitamin D target genes. Such a model would explain the action of 1,25(OH)2D3 to elicit bone remodeling by stimulating osteoblast and osteoclast precursor gene expression, while concomitantly triggering the termination of its hormonal signal by inducing the 24-OHase catabolizing enzyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Francis, F., Hennig, S., Korn, B., Reinhardt, R., de Jong, P., Poustka, A., Lehrach, H., Rowe, P. S. N., Goulding, J. N., Summerfield, T., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-130 · Cited by 1,107
Differential Recognition of Target Genes by Nuclear Receptor Monomers, Dimers, and Heterodimers*
GLASS, C. K. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-391 · Cited by 829
Danielian, P. S., White, R., Lees, J. A., & Parker, M. G. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05141.x · Cited by 803
Fawell, S. (1990) · Cell · doi:10.1016/0092-8674(90)90343-d · Cited by 598
Basic and Clinical Concepts Related to Vitamin D Metabolism and Action: (First of Two Parts)
Haussler, M. R., & McCain, T. A. (1977) · New England Journal of Medicine · doi:10.1056/nejm197711032971804 · Cited by 575
Self-citationStructural determinants of nuclear receptor assembly on DNA direct repeats
Rastinejad, F., Perlmann, T., Evans, R. M., & Sigler, P. B. (1995) · Nature · doi:10.1038/375203a0 · Cited by 564
TRANSCRIPTION ACTIVATION BY ESTROGEN AND PROGESTERONE RECEPTORS
Gronemeyer, H. (1991) · Annual Review of Genetics · doi:10.1146/annurev.ge.25.120191.000513 · Cited by 378
Vitamin D Receptors: Nature and Function
Haussler, M. R. (1986) · Annual Review of Nutrition · doi:10.1146/annurev.nu.06.070186.002523 · Cited by 367
Self-citationTumor-Induced Osteomalacia -- Unveiling a New Hormone
Econs, M. J., & Drezner, M. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302310 · Cited by 226
Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice
Dr. Meyer, R. A., Meyer, M. H., & Gray, R. W. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040407 · Cited by 209
Cited by
The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
Haussler, M. R., Whitfield, G. K., Haussler, C. A., Hsieh, J.-C., Thompson, P. D., Selznick, S. H., Dominguez, C. E., & Jurutka, P. W. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.325 · Cited by 1,421
Self-citationAnatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T., Evans, R. M., & Mangelsdorf, D. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.049 · Cited by 1,015
Immunologic Effects of Vitamin D on Human Health and Disease
Charoenngam, N., & Holick, M. F. (2020) · Nutrients · doi:10.3390/nu12072097 · Cited by 967
Vitamin D and Endothelial Function
Kim, D.-H., Meza, C. A., Clarke, H., Kim, J.-S., & Hickner, R. C. (2020) · Nutrients · doi:10.3390/nu12020575 · Cited by 379
Dzik, K. P., & Kaczor, J. J. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04104-x · Cited by 357
Metadata
- Authors
- Haussler, M. R., Haussler, C. A., Jurutka, P. W., Thompson, P. D., Hsieh, J., Remus, L. S., Selznick, S. H., & Whitfield, G. K.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 1997-01-01
- Volume
- 154
- Issue
- 3_Suppl
- Pages
- S57-S73
- ISSN
- 0022-0795 (ISSN-L)
- OpenAlex
- W2164301360
- Cited by
- 333
- References
- 15
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The vitamin D hormone and its nuclear receptor: molecular actions and disease states. https://app.cochat.ai/papers/10.1677/joe.0.154s057
- The paper
- Haussler, M. R., Haussler, C. A., Jurutka, P. W., Thompson, P. D., Hsieh, J., Remus, L. S., Selznick, S. H., & Whitfield, G. K. (1997). The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Journal of Endocrinology. https://doi.org/10.1677/joe.0.154s057
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.